CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors
Therapy resistance is a significant concern while treating malignant disease. Accumulating evidence suggests that a subset of cancer cells potentiates tumor survival, therapy resistance, and relapse. Several different pathways regulate these purported cancer stem cells (CSCs). Evidence shows that th...
| Published in: | Biomedicines |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-02-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/11/2/576 |